NYBC Ventures
Early-stage life sciences VC fund accelerating breakthroughs in blood, cellular therapies, hematology, transfusion medicine, and infectious disease.
Boston, United States · 3+ investments · 3 portfolio companies
- Headquarters
- Boston, United States
- Founded
- 2021
- Website
- nybcventures.com
- AUM
- $50.0M
- Portfolio Companies
- 3
- Total Investments
- 3
- Last Investment
- Dec 2025
- Geographic Focus
- United States
Investment Thesis
NYBC Ventures is a Venture Capital firm based in Boston, United States. It has made 3 investments, including Cellular Origins, Avencell and Veralox Therapeutics. Focus areas include Cell Therapy and Hematology.
Portfolio3
Co-investors17
Sign up to view co-investors
17 co-investors across 17 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×15 · Growth Equity ×1 · Corporate VC ×1 · 10 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/nybc-ventures"><img src="https://indexed.vc/api/badge/investor/nybc-ventures" alt="NYBC Ventures on Indexed.vc" width="260" height="76" /></a>